NCT01622335

Brief Summary

The study is prospective and double blind. In the clinic, patients undergoing hysterectomy that meet the criteria for inclusion into the study and agreed to participate in the study will be randomized into two groups.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 15, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 19, 2012

Completed
10.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

10.6 years

First QC Date

June 15, 2012

Last Update Submit

May 6, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Nitrous oxide and chronic pain

    The of the effect of 50% N20/50% O2 on post hysterectomy in prevention of chronic pain.

    30 days post operative

  • Nitrous oxide and opioid consumption

    The effect of 50% N20/50% O2 on post hysterectomy in decrease of opioid consumption.

    4 hours post operative

Study Arms (2)

General anesthesia with oxygen

PLACEBO COMPARATOR

General anesthesia and Air

Other: General anesthesia with oxygen

nitrous oxide and general anesthesia

EXPERIMENTAL

General anesthesia with Nitrous Oxide

Drug: Nitrous oxide

Interventions

General anesthesia with Nitrous Oxide, 70%, O2 30%) 1-5 L, Sevoflurane 1-2%, ETCO2: 32-35 mmHg.

nitrous oxide and general anesthesia

General anesthesia with(Air, 70%, O2 30%) 1-5 L, Sevoflurane 1-2%, ETCO2: 32-35 mmHg.

General anesthesia with oxygen

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to 65 years old at time of the first procedure
  • Female
  • American Society of Anesthesiologists physical status I or II
  • Hysterectomy undergoing the general anesthesia

You may not qualify if:

  • Neuropathic disease
  • Chronic opioid users
  • Contraindication for Nitrous Oxide receive
  • Consent will not be obtained patient
  • Psychiatric disorders
  • Current or recent drug abuse (within past 6 months).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulhane Military Medical Academy Hospital

Etlik, Ankara, 06018, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Nitrous OxideAnesthesia, GeneralOxygen

Intervention Hierarchy (Ancestors)

Nitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen CompoundsAnesthesiaAnesthesia and AnalgesiaChalcogensElements

Study Officials

  • Alparslan Turan, M.D.

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigatgor

Study Record Dates

First Submitted

June 15, 2012

First Posted

June 19, 2012

Study Start

May 1, 2012

Primary Completion

December 1, 2022

Study Completion

December 1, 2023

Last Updated

May 7, 2024

Record last verified: 2024-05

Locations